Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
In 95 leukaemic cell samples from 66 patients with acute myelogenous leukaemia (AML) (47 de novo and 19 secondary AML) telomerase activity was determined and the expression of the telomerase components: telomerase reverse transcriptase (hTERT), telomerase RNA template (hTR) and telomerase‐associated protein (TP1) evaluated by RT‐PCR. Compared to peripheral blood mononuclear cells (PBMC) from normal adult 87% (82/95) of patient samples exhibited elevated telomerase activity. hTERT, but not hTR and TP1 expression strongly correlated with the levels of telomerase activity (r = 0.47, P < 0.0001). The levels of telomerase activity were significantly higher at time of relapse or progression than at time of diagnosis (P = 0.003), and correlated to CD34 expression and chromosomal abnormalities of leukaemic cells (P = 0.01 and P = 0.001 respectively). The rate and duration of complete remission (CR) did not correlate with the levels of telomerase activity at diagnosis. Among eight patients in first relapse, however, two of three with low levels of telomerase activity re‐entered CR, whereas none of five patients with high telomerase activity achieved a second CR. Taken together, telomerase activation/up‐regulation in AML is a disease progression‐associated event. Undifferentiated status and chromosomal aberration also lead to the up‐regulation of telomerase activity in AML.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 3×
“A commercial telomerase PCR ELISA kit (Boehringer Mannheim, Mannheim, Germany), based on TRAP introduced by Kim et al (1994), was used to determine telomerase activity in all specimens.”
BackgroundMethodExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Structure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · cited 2×
“…(hTR) and telomerase-associated protein (TP1) showed that hTR and TP1 were expressed in both normal and malignant human cells and that their expression did not relate to telomerase activity (Feng et al, 1995; Harrington et al, 1997; Kuniyasu et al, 1997; Nakamura et al, 1997; Soder et al, 1997).”
BackgroundMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784 · cited 5×
“Most recently, the gene encoding the human telomerase catalytic subunit called telomerase reverse transcriptase (hTERT), was cloned (Meyerson et al, 1997; Nakamura et al, 1997).”
BackgroundInfluentialActivation of telomerase in human lymphocytes and hematopoietic progenitor cells
Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., & Yamakido, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3711 · Cited by 853
Telomerase activity in human ovarian carcinoma.
Counter, C. M., Hirte, H. W., Bacchetti, S., & Harley, C. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.2900 · Cited by 677 · cited 1×
“…has two important consequences in cell biology: (1) it confers immortal phenotype and proliferation advantage to malignant cells (Counter et al, 1994; Harley et al, 1994), and (2) it protects cells from DNA damage caused by chemotherapeutic agents, thus possibly conferring…”
BackgroundTelomerase, Cell Immortality, and Cancer
Harley, C. B., Kim, N. W., Prowse, K. R., Weinrich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M., Greider, C. W., et al. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.035 · Cited by 396
Chiu, C., Dragowska, W., Kim, N. W., Vaziri, H., Yui, J., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1996) · STEM CELLS · doi:10.1002/stem.140239 · Cited by 388 · cited 3×
“…T lymphocytes in quiesence express very low levels of telomerase activity, but upon appropriate stimulation to actively proliferate these cells drastically increase their expression of telomerase activity and hTR (Chiu et al, 1996; Hiyama, K., et al, 1995; Norrback et al, 1996; Weng et al, 1997).”
BackgroundMethod
Cited by
Xu, D., Popov, N., Hou, M., Wang, Q., Björkholm, M., Gruber, A., Menkel, A. R., & Henriksson, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071043198 · Cited by 325
Self-citationActivity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)
Poole, J. C., Andrews, L. G., & Tollefsbol, T. O. (2001) · Gene · doi:10.1016/s0378-1119(01)00440-1 · Cited by 274
Xu, D., Wang, Q., Gruber, A., Björkholm, M., Chen, Z., Zaid, A., Selivanova, G., Peterson, C., Wiman, K. G., & Pisa, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203890 · Cited by 257
Self-citationHou, M., Xu, D., Björkholm, M., & Gruber, A. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.519 · Cited by 175
Self-citationZhang, X., Li, B., de Jonge, N., Björkholm, M., & Xu, D. (2015) · Oncotarget · doi:10.18632/oncotarget.2917 · Cited by 38
Self-citation
Metadata
- Authors
- XU, D., Gruber, A., Peterson, C., & Pisa, P.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1998-09
- Volume
- 102
- Issue
- 5
- Pages
- 1367-1375
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W1910707300
- Cited by
- 107
- References
- 10
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. https://app.cochat.ai/papers/10.1046/j.1365-2141.1998.00969.x
- The paper
- XU, D., Gruber, A., Peterson, C., & Pisa, P. (1998). Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.1998.00969.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.